However, despite mechanistically promising in vitro data, the synergistic effect endowed by the enolase and glutaminase inhibitors could not be entirely recapitulated in vivo in both orthotopic (intracranial) and subcutaneous tumor models. Here, GLS is linked to neoplasm.